Defining Resistance Mechanisms to Selective RET Tyrosine Kinase Inhibitors in RET Fusion-Positive Non-Small Cell Lung Cancer (editorial re: Lin et al.)

Lung Cancer
13/10/2020

Ann Oncol. 2020 Oct 9:S0923-7534(20)42493-7. doi: 10.1016/j.annonc.2020.10.002. Online ahead of print.

NO ABSTRACT